Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma

被引:41
|
作者
Homburg, Ursula [1 ]
Renz, Harald [2 ,3 ]
Timmer, Wolfgang
Hohlfeld, Jens M. [4 ]
Seitz, Friedeborg [5 ]
Lueer, Katrin [4 ]
Mayer, Alexandra [5 ]
Wacker, Anja [6 ]
Schmidt, Oliver [6 ]
Kuhlmann, Jens [1 ]
Turowska, Agnieszka [1 ]
Roller, Julia [7 ]
Kutz, Klaus [8 ]
Schlueter, Gerhard
Krug, Norbert [4 ]
Garn, Holger [2 ,3 ]
机构
[1] Sterna Biol GmbH, Marburg, Germany
[2] Univ Giessen, Univ Marburg, Fac Med, Inst Lab Med & Pathobiochem Mol Diagnost, Marburg, Germany
[3] Marburg Lung Ctr UGMLC, Marburg, Germany
[4] Fraunhofer Inst Toxicol & Expt Med, Dept Clin Airway Res, Hannover, Germany
[5] CRS Clin Res Serv Mannheim GmbH, Mannheim, Germany
[6] Engelhard Arzneimittel GmbH, Niederdorfelden, Germany
[7] Vectura GmbH, Gauting, Germany
[8] AccelPharm, Basel, Switzerland
关键词
GATA-3-SPECIFIC DNAZYME; ACTIVATION; EXPRESSION; TOXICITY; EXPOSURE; HGD40;
D O I
10.1016/j.jaci.2015.02.018
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:797 / +
页数:4
相关论文
共 41 条
  • [21] Efficacy and safety of single inhaled doses of LAS100977, a novel long acting β2-agonist in patients with persistent asthma
    Beier, J.
    Fuhr, R.
    Massana, Eric
    Jimenez, E.
    Seoane, B.
    de Miquel, G.
    Ruiz, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [22] Efficacy, Safety And Tolerability Of Abediterol (las100977), A Novel Long Acting β2-Adrenergic Agonist, In Patients With Persistent Asthma
    Beier, J.
    Seoane, B.
    Massana, E.
    De Miquel, G.
    Pujol, H.
    Ruiz, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [24] T-bet/GATA-3 ratio is a surrogate measure of Th1/Th2 cytokine profiles and may be novel targets for CpG ODN treatment in asthma patients
    Dong Liang
    Chen Ming
    Zhang Qi
    Li Li-zheng
    Xu Xiao-qun
    Xiao Wei
    CHINESE MEDICAL JOURNAL, 2006, 119 (16) : 1396 - 1399
  • [25] Safety and tolerability of the novel inhaled corticosteroid (ICS) fluticasone furoate (FF) in combination with the long-acting beta2 agonist (LABA) vilanterol (VI) administered once daily (OD) in patients with asthma
    Busse, William W.
    O'Byrne, Paul M.
    Bleecker, Eugene R.
    Lotvall, Jan
    Woodcock, Ashley
    Andersen, Leslie
    West, Jody
    Jacques, Loretta
    Apoux, Ludovic
    Bateman, Eric D.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [26] Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease
    Sadiq, Muhammad Waqas
    Asimus, Sara
    Belvisi, Maria G.
    Brailsford, Wayne
    Fransson, Rebecca
    Fuhr, Rainard
    Hagberg, Anette
    Hashemi, Mahdi
    Jensen, Tina Jellesmark
    Jonsson, Julia
    Keen, Christina
    Koernicke, Thomas
    Kristensson, Cecilia
    Maenpaa, Jukka
    Necander, Sofia
    Nemes, Szilard
    Betts, Joanne
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 260 - 270
  • [27] Tolerability of indacaterol, a novel once-daily β2-agonist, in patients with asthma:: a randomized, placebo-controlled, 28-day safety study
    Yang, William H.
    Martinot, Jean Benoit
    Pohunek, Petr
    Beier, Jutta
    Magula, Daniel
    Cameron, Ray
    Owen, Roger
    Higgins, Mark
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 99 (06) : 555 - 561
  • [28] Novel immunostimulators with a thiazolidin-4-one ring promote the immunostimulatory effect of human iNKT cells on the stimulation of Th2-like immune responsiveness via GATA3 activation in vitro
    Meng, Ming
    Li, Chunxiao
    Yang, Fei
    Chen, Hua
    Li, Xiaoliu
    Yang, Yongbin
    Chen, Dongzhi
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 39 : 353 - 358
  • [29] Picroside II Attenuates Airway Inflammation by Downregulating the Transcription Factor GATA3 and Th2-Related Cytokines in a Mouse Model of HDM-Induced Allergic Asthma (vol 11, e0167098, 2016)
    Choi, Jin
    Choi, Bo Kyong
    Kim, Jin Seok
    Lee, Jae-Won
    Park, Hyun Ah
    Ryu, Hyung Won
    Lee, Su Ui
    Hwang, Kwang Woo
    Yun, Won-Kee
    Kim, Hyoung-Chin
    Ahn, Kyung-Seop
    Oh, Sei-Ryang
    Lee, Hyun-Jun
    PLOS ONE, 2017, 12 (01):
  • [30] PSORI-CM02 alleviates IMQ-induced mouse dermatitis via differentially regulating pro- and anti-inflammatory cytokines targeting of Th2 specific transcript factor GATA3
    Wu, Ding-hong
    Zhang, Miao-miao
    Li, Ning
    Li, Xiong
    Cai, Quan-wei
    Yu, Wan-lin
    Liu, Li-ping
    Zhu, Wei
    Lu, Chuan-jian
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 265 - 274